In this study, we have two objectives: (1) to extend prior studies by estimating the cost attributable to colon cancer 1-year after diagnosis by cancer stage, comorbidity, treatment regimen, and other patient characteristics; and (2) to estimate the differences in 1-year cost between Medicare only and the dually eligible beneficiaries.